SCHEMBL260446

SCHEMBL260446

CCC(=O)N(CCNC)CC(C)=O

nearest known ligand 0.35

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
PRMT3 O60678 1/20 0.33
CARM1 Q86X55 1/20 0.33
PRMT6 Q96LA8 1/20 0.33
PRMT1 Q99873 1/20 0.33
PRMT8 Q9NR22 1/20 0.33
KDM4A O75164 1/20 0.31
KDM4C Q9H3R0 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14128720 0.90 MEN1 (0.32)
SCHEMBL13500395 0.90 MEN1 (0.32)
SCHEMBL6123945 0.89 KDM4A (0.36) ALDH1A1TDP1KDM4AKDM4C
SCHEMBL27003670 0.86 PRMT3 (0.40) ALDH1A1PRMT3CARM1PRMT6PRMT1
SCHEMBL12933032 0.85 ALDH1A1 (0.35) ALDH1A1PRMT3CARM1PRMT6PRMT1
SCHEMBL24036624 0.85 PRMT3 (0.33) PRMT3CARM1PRMT6PRMT1PRMT8
SCHEMBL14445500 0.85 PRMT3 (0.33) PRMT3CARM1PRMT6PRMT1PRMT8
SCHEMBL26652081 0.84
SCHEMBL6123949 0.83 PAOX (0.34) ALDH1A1TDP1PRMT3CARM1PRMT6
SCHEMBL1644155 0.83 PRMT3 (0.32) PRMT3CARM1PRMT6PRMT1PRMT8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230295614-A1 METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF ARGININOSUCCINATE LYASE (ASL) KORRO BIO, INC. 2023-09-21 US disclosed
US-20230190968-A1 ANTI-CD38 SINGLE-DOMAIN ANTIBODIES IN DISEASE MONITORING AND TREATMENT Université de Liège (BE) 2023-06-22 US disclosed
US-20230174989-A1 Methods and Compositions for the ADAR-Mediated Editing of ABCA4 KORRO BIO, INC. (US) 2023-06-08 US disclosed
US-9975870-B2 5,6-dimethoxy-1,1-dioxobenzo[b]thiophene-2-methyloxycarbonyl (DM-Bsmoc) and related amino-protecting groups MASSACHUSETTS, UNIVERSITY OF (US) 2018-05-22 US disclosed
US-20170183655-A1 COMPOSITIONS AND USES FOR TREATMENT THEREOF BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE 2017-06-29 US disclosed
US-20170073748-A1 METHODS AND COMPOSITIONS FOR GENOMIC TARGET ENRICHMENT AND SELECTIVE DNA SEQUENCING PetaOmics, Inc. 2017-03-16 US disclosed
US-20170002355-A1 cGAP-PNA MULTIVALENT PEPTIDE NUCLEIC ACID LIGAND DISPLAY THE USA, AS REPRESENTED BY THE SECRETARY, DEPART- MENT OF HEALTH AND HUMAN SERVICES (US) 2017-01-05 US disclosed
US-20160152591-A1 THE 5,6-DIMETHOXY-1,1-DIOXOBENZO[B]THIOPHENE-2-METHYLOXYCARBONYL (DM-BSMOC) AND RELATED AMINO-PROTECTING GROUPS MASSACHUSETTS, UNIVERSITY OF 2016-06-02 US disclosed
US-9156778-B2 Cross-coupled peptide nucleic acids for detection of nucleic acids of pathogens THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2015-10-13 US disclosed
US-20140148500-A1 PROGRAMMABLE SELF-ASSEMBLED NANOSTRUCTURES BASED ON SIDECHAIN-MODIFIED PNA FOR THE MULTIVALENT DISPLAY OF LIGANDS THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2014-05-29 US disclosed
US-8450469-B2 Synthesis of peptide nucleic acids conjugated with amino acids and their application PANAGENE INC. (KR) 2013-05-28 US disclosed
US-20120322053-A1 CROSS-COUPLED PEPTIDE NUCLEIC ACIDS FOR DETECTION OF NUCLEIC ACIDS OF PATHOGENS APPELLA DANIEL H (US) 2012-12-20 US disclosed
US-20120107794-A1 Cross-Coupled Peptide Nucleic Acids for Detection of Nucleic Acids of Pathogens THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES 2012-05-03 US disclosed
US-8133985-B2 Peptide nucleic acids conjugated with multi-amine linkers and nucleic acid detecting device using the same PANAGENE INC. (KR) 2012-03-13 US disclosed
US-20110014715-A1 Synthesis of Peptide Nucleic Acids Conjugated with Amino Acids and Their Application PANAGENE INC. (KR) 2011-01-20 US disclosed
US-7642057-B2 Method and probes for the detection of chromosome aberrations DAKO DENMARK A/S (DK) 2010-01-05 US disclosed
US-20090312197-A1 PEPTIDE NUCLEIC ACIDS CONJUGATED WITH MULTI-AMINE LINKERS AND NUCLEIC ACID DETECTING DEVICE USING THE SAME PANAGENE INC. (KR) 2009-12-17 US disclosed
US-20080187934-A1 Using peptide nucleic acid probes to detect chromosome aberrations in eukaryotic cells DAKO A/S (DK) 2008-08-07 US disclosed
US-7368245-B2 Method and probes for the detection of chromosome aberrations DAKO DENMARK A/S (DK) 2008-05-06 US disclosed
US-20070172842-A1 Methods for isolating and identifying novel target-specific structuremers for use in the biological sciences BRAUN ANDREAS 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312197-A1 PEPTIDE NUCLEIC ACIDS CONJUGATED WITH MULTI-AMINE LINKERS AND NUCLEIC ACID DETECTING DEVICE USING THE SAME NPPA, PARN, PARG ALDH1A1 3477/4885TDP1 230/4885PRMT3 535/4885
US-20230190968-A1 ANTI-CD38 SINGLE-DOMAIN ANTIBODIES IN DISEASE MONITORING AND TREATMENT CD38, CD22, CD2 ALDH1A1 681/4885TDP1 837/4885PRMT3 3007/4885
US-20170002355-A1 cGAP-PNA MULTIVALENT PEPTIDE NUCLEIC ACID LIGAND DISPLAY CGAS, STING1, IAPP ALDH1A1 4744/4885TDP1 56/4885PRMT3 2443/4885
US-20140148500-A1 PROGRAMMABLE SELF-ASSEMBLED NANOSTRUCTURES BASED ON SIDECHAIN-MODIFIED PNA FOR THE MULTIVALENT DISPLAY OF LIGANDS NCL, PARN, COIL ALDH1A1 4738/4885TDP1 662/4885PRMT3 2473/4885
US-20230174989-A1 Methods and Compositions for the ADAR-Mediated Editing of ABCA4 ADAR, ABCB4, ADA ALDH1A1 391/4885TDP1 60/4885PRMT3 3957/4885
US-20230295614-A1 METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF ARGININOSUCCINATE LYASE (ASL) ADAR, ADA, ASS1 ALDH1A1 725/4885TDP1 64/4885PRMT3 313/4885
US-20160152591-A1 THE 5,6-DIMETHOXY-1,1-DIOXOBENZO[B]THIOPHENE-2-METHYLOXYCARBONYL (DM-BSMOC) AND RELATED AMINO-PROTECTING GROUPS DAO, DDC, PTMS ALDH1A1 4651/4885TDP1 1834/4885PRMT3 178/4885
US-20110014715-A1 Synthesis of Peptide Nucleic Acids Conjugated with Amino Acids and Their Application CPSF6, RNGTT, DNPEP ALDH1A1 4448/4885TDP1 2021/4885PRMT3 1448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.